These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7148760)

  • 1. Comparison of effectiveness of pancreatic enzyme preparations in cystic fibrosis.
    Mischler EH; Parrell S; Farrell PM; Odell GB
    Am J Dis Child; 1982 Dec; 136(12):1060-3. PubMed ID: 7148760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between a standard pancreatic supplement and a high enzyme preparation in cystic fibrosis.
    Morrison G; Morrison JM; Redmond AO; Byers CA; McCracken KJ; Dodge JA; Guilford SA; Bowden MW
    Aliment Pharmacol Ther; 1992 Oct; 6(5):549-55. PubMed ID: 1420747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
    Kalnins D; Ellis L; Corey M; Pencharz PB; Stewart C; Tullis E; Durie PR
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical examination of therapeutic efficacy of a pH-sensitive enteric-coated pancreatic enzyme preparation in treatment of exocrine pancreatic insufficiency secondary to cystic fibrosis.
    Dutta SK; Hubbard VS; Appler M
    Dig Dis Sci; 1988 Oct; 33(10):1237-44. PubMed ID: 3168696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUR-1008 pancreatic enzyme replacement is safe and effective in patients with cystic fibrosis and pancreatic insufficiency.
    Wooldridge JL; Heubi JE; Amaro-Galvez R; Boas SR; Blake KV; Nasr SZ; Chatfield B; McColley SA; Woo MS; Hardy KA; Kravitz RM; Straforini C; Anelli M; Lee C
    J Cyst Fibros; 2009 Dec; 8(6):405-17. PubMed ID: 19683970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients.
    Gan KH; Heijerman HG; Geus WP; Bakker W; Lamers CB
    Aliment Pharmacol Ther; 1994 Dec; 8(6):603-7. PubMed ID: 7696449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS; Garson JL; Krug SK; Kaul A; Rickard KA; Caffrey HH; Fineberg N; Balistreri WF; Stevens JC
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
    Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative in vitro and in vivo studies of enteric-coated pancrelipase preparations for pancreatic insufficiency.
    Thomson M; Clague A; Cleghorn GJ; Shepherd RW
    J Pediatr Gastroenterol Nutr; 1993 Nov; 17(4):407-13. PubMed ID: 8145097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy and tolerance of pancrelipase and placebo in the treatment of steatorrhea in cystic fibrosis patients with clinical exocrine pancreatic insufficiency.
    Stern RC; Eisenberg JD; Wagener JS; Ahrens R; Rock M; doPico G; Orenstein DM
    Am J Gastroenterol; 2000 Aug; 95(8):1932-8. PubMed ID: 10950038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two enteric coated microsphere preparations in the treatment of pancreatic exocrine insufficiency caused by cystic fibrosis.
    Santini B; Antonelli M; Battistini A; Bertasi S; Collura M; Esposito I; Di Febbraro L; Ferrari R; Ferrero L; Iapichino L; Lucidi V; Manca A; Pisconti CL; Pisi G; Raia V; Romano L; Rosati P; Grazioli I; Melzi G
    Dig Liver Dis; 2000; 32(5):406-11. PubMed ID: 11030186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of pancrease: crossover comparative study versus eurobiol in cystic fibrosis.
    Chazalette JP; Dain MP; Castaigne JP
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S46-8. PubMed ID: 3042939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of a Novel Microbial Lipase in Patients with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis: A Randomized Controlled Clinical Trial.
    Heubi JE; Schaeffer D; Ahrens RC; Sollo N; Strausbaugh S; Graff G; Jain R; Witte S; Forssmann K
    J Pediatr; 2016 Sep; 176():156-161.e1. PubMed ID: 27297209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of malabsorption in cystic fibrosis: influence of recent developments on clinical practice.
    Littlewood JM
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S56-62; discussion S59-62. PubMed ID: 8869184
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of gastrointestinal pH in cystic fibrosis and healthy subjects.
    Youngberg CA; Berardi RR; Howatt WF; Hyneck ML; Amidon GL; Meyer JH; Dressman JB
    Dig Dis Sci; 1987 May; 32(5):472-80. PubMed ID: 3646103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.